Program overview
Context
Indication: Head and Neck Squamous Cell Carcinoma
Mechanism: Unknown
Modality: Unknown
Sponsor: ImmunityBio, .
Registry Stop Signal
Avelumab
Avelumab is flagged as registry stop signal because public records show a registry stop signal, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 5/5
Timeline: 1/5
Recruitment burden: 3/5
Results availability: 0/5
Program risk: 4/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT03169764 | https://clinicaltrials.gov/study/NCT05327686
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT03169764 | Registry Stop Signal (WITHDRAWN) | stale_update_signal | Low Signal | rare_population_signal | strict_eligibility_signal |
| NCT05327686 | Low Signal (RECRUITING) | long_recruitment_duration_signal | Low Signal | large_enrollment_target_signal | rare_population_signal | strict_eligibility_signal |